Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Family history of cancer and gastroesophageal disorders and risk of esophageal and gastric adenocarcinomas: a case-control study.

Jiang X, Tseng CC, Bernstein L, Wu AH.

BMC Cancer. 2014 Feb 4;14:60. doi: 10.1186/1471-2407-14-60.

2.
3.

Family history of cancer and risk of esophageal and gastric cancers in the United States.

Dhillon PK, Farrow DC, Vaughan TL, Chow WH, Risch HA, Gammon MD, Mayne ST, Stanford JL, Schoenberg JB, Ahsan H, Dubrow R, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr.

Int J Cancer. 2001 Jul 1;93(1):148-52.

4.
5.

Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County.

Duan L, Wu AH, Sullivan-Halley J, Bernstein L.

Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):126-34. doi: 10.1158/1055-9965.EPI-07-0664. Epub 2008 Jan 9.

6.
7.

Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.

Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, Nyrén O.

J Natl Cancer Inst. 2004 Mar 3;96(5):388-96.

PMID:
14996860
8.

Heredity and risk of cancer of the esophagus and gastric cardia.

Lagergren J, Ye W, Lindgren A, Nyrén O.

Cancer Epidemiol Biomarkers Prev. 2000 Jul;9(7):757-60.

9.

Antacid drug use and risk of esophageal and gastric adenocarcinomas in Los Angeles County.

Duan L, Wu AH, Sullivan-Halley J, Bernstein L.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):526-33. doi: 10.1158/1055-9965.EPI-08-0764. Epub 2009 Feb 3.

10.

The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia.

Chow WH, Finkle WD, McLaughlin JK, Frankl H, Ziel HK, Fraumeni JF Jr.

JAMA. 1995 Aug 9;274(6):474-7.

PMID:
7629956
11.

GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas.

Wideroff L, Vaughan TL, Farin FM, Gammon MD, Risch H, Stanford JL, Chow WH.

Cancer Detect Prev. 2007;31(3):233-6. Epub 2007 Jul 23.

12.

Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC).

González CA, Jakszyn P, Pera G, Agudo A, Bingham S, Palli D, Ferrari P, Boeing H, del Giudice G, Plebani M, Carneiro F, Nesi G, Berrino F, Sacerdote C, Tumino R, Panico S, Berglund G, Simán H, Nyrén O, Hallmans G, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quirós JR, Allen N, Key TJ, Day NE, Linseisen J, Nagel G, Bergmann MM, Overvad K, Jensen MK, Tjonneland A, Olsen A, Bueno-de-Mesquita HB, Ocke M, Peeters PH, Numans ME, Clavel-Chapelon F, Boutron-Ruault MC, Trichopoulou A, Psaltopoulou T, Roukos D, Lund E, Hemon B, Kaaks R, Norat T, Riboli E.

J Natl Cancer Inst. 2006 Mar 1;98(5):345-54.

PMID:
16507831
13.

Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors.

Zhang ZF, Kurtz RC, Sun M, Karpeh M Jr, Yu GP, Gargon N, Fein JS, Georgopoulos SK, Harlap S.

Cancer Epidemiol Biomarkers Prev. 1996 Oct;5(10):761-8.

14.

Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.

Vaughan TL, Farrow DC, Hansten PD, Chow WH, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Rotterdam H, Dubrow R, Ahsan H, West AB, Blot WJ, Fraumeni JF Jr.

Cancer Epidemiol Biomarkers Prev. 1998 Sep;7(9):749-56.

15.

Fiber intake and risk of adenocarcinomas of the esophagus and stomach.

Wu AH, Tseng CC, Hankin J, Bernstein L.

Cancer Causes Control. 2007 Sep;18(7):713-22. Epub 2007 Jun 12.

PMID:
17562192
16.

Diabetes and risk of esophageal and gastric adenocarcinomas.

Jiang X, Bernstein L, Tseng CC, Wu AH.

Int J Cancer. 2012 Sep 15;131(6):1417-22. doi: 10.1002/ijc.27390. Epub 2012 Jan 11.

17.

Occupational physical activity and risk of adenocarcinomas of the esophagus and stomach.

Vigen C, Bernstein L, Wu AH.

Int J Cancer. 2006 Feb 15;118(4):1004-9.

19.
20.

Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.

Farrow DC, Vaughan TL, Sweeney C, Gammon MD, Chow WH, Risch HA, Stanford JL, Hansten PD, Mayne ST, Schoenberg JB, Rotterdam H, Ahsan H, West AB, Dubrow R, Fraumeni JF Jr, Blot WJ.

Cancer Causes Control. 2000 Mar;11(3):231-8.

PMID:
10782657

Supplemental Content

Support Center